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Abstract. Insights into the etiology of stroke and myocar-
dial infarction suggest that rupture of unstable athero-
sclerotic plaque is the precipitating event. Clinicians lack
tools to detect lesion instability early enough to intervene,
and are often left to manage patients empirically, or worse,
after plaque rupture. Noninvasive imaging of the molecular
events signaling prerupture plaque progression has the
potential to reduce the morbidity and mortality associated
with myocardial infarction and stroke by allowing early
intervention. Here, we demonstrate proof-of-principle in
vivomolecular imaging of C-type natriuretic peptide recep-
tor in focal atherosclerotic lesions in the femoral arteries of
New Zealand white rabbits using a custom built fiber-
based, fluorescence molecular tomography (FMT) system.
Longitudinal imaging showed changes in the fluorescence
signal intensity as the plaque progressed in the air-desic-
cated vessel compared to the uninjured vessel, which was
validated by ex vivo tissue studies. In summary, we dem-
onstrate the potential of FMT for noninvasive detection of
molecular events leading to unstable lesions heralding
plaque rupture. © The Authors. Published by SPIE under a Creative
Commons Attribution 3.0 Unported License. Distribution or reproduction of
this work in whole or in part requires full attribution of the original publication,
including its DOI. [DOI: 10.1117/1.JBO.19.11.110501]
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Carotid artery atherosclerosis is classified as an important cause
of stroke. Unstable plaque is characterized by an eccentric neo-
intimal lesion with a lipid core covered by a thinning cap of
smooth muscle cells, active angiogenesis, increased matrix
metalloproteinase activity, and translocation of monocyte/
macrophages that transform into foam cells. Timely noninvasive
imaging that could signal prerupture plaque progression will
reduce the morbidity and mortality by allowing early interven-
tion.1 Although positron emission tomography (PET) and mag-
netic resonance imaging (MRI) are routinely used for metabolic
and morphologic imaging, these modalities are not suited for
frequent monitoring or even screening of at-risk patients
because of ionizing radiation (PET) and expense (PET, MRI).
Transcutaneous Doppler and intravascular ultrasound are insen-
sitive to the subtle molecular changes of critical importance.
Fluorescence molecular tomography (FMT) is an emerging opti-
cal imaging technology that allows tomographic and quantita-
tive visualization of molecular events in vivo.2 In this study,
a custom built, fiber-based, portable, video-rate FMT system
was used for proof-of-principle studies to detect C-type natriu-
retic peptide receptors (NPR-C) on focal atherosclerotic lesions
in the superficial rabbit femoral arteries. The FMT system con-
sisted of a flexible imaging pad (3 cm × 3 cm), containing 12
sources 785 nm 20 kHz, and 830 nm 17-kHz laser diodes as exci-
tation source and reference, respectively.3 The detectors allowed
for dynamic concurrent acquisition of frequency encoded fluores-
cence emission (830 nm; 20 kHz) and transmission reference
(830 nm; 17 kHz) signals for the fast generation of ratio-metric
data for tomographic reconstruction of the tissue volume. The
system could report varying concentrations (1 nM to 1 μM) of
indocyanine green at various depths up to 13.5 mm with a
depth-dependent spatial resolution on the order of 12 mm.3
We used a model of focal atherosclerotic-like plaques in the
femoral arteries (located ∼1 to 1.5 cm from skin surface) of New
Zealand white rabbits. All animal studies performed were
approved by the Washington University Animal Studies
Committee. Endothelial denudation of surgically exposed right
femoral artery was induced by air desiccation of the luminal sur-
face as described previously.4 The uninjured left femoral artery
served as the internal control. The animals were maintained on a
cholesterol-enriched diet (>200 mg∕dL in blood), and over
time the air desiccation led to a focal lesion. In this animal
model, anatomical coregistration was not used because the loca-
tion of the lesion was apparent due to the surgical markings and
identification by the surgeon at each imaging session. In a clini-
cal setting, coregistration of the FMT probe with the ultra sound
(US) probe can be utilized. We chose to monitor the progression
of the receptor, NPR-C, which has been shown to undergo
changes during atherosclerotic plaque progression and was
recently evaluated as a PET imaging marker.5 NPR-C is a cell
surface protein found on endothelial, vascular smooth muscle,
and macrophage cells. Natriuretic peptides (NPs) play an impor-
tant role in regulating cardiovascular homeostasis. NPR-C
(clearance receptor) removes NPs from circulation by receptor
mediated endocytosis.6 We evaluated a bioconjugate LS668
(Cypate-RSSc[CFGGRIDRIGAC]), consisting of a near infra-
red (NIR) fluorescent dye cypate conjugated to a targeting
peptide, C-type atrial natriuretic peptide, specific for NPR-C
[Fig. 1(a)]. NIR fluorescent (700 to 900 nm) imaging agents
are desirable for in vivo imaging due to enhanced depth penetra-
tion of NIR light and low tissue autofluorescence.7 Cell studies
demonstrated that LS668 (1 μM, 30-min incubation at 37°C, 5%
CO2) was selectively internalized by stably transfected 293T-
NPR-C cells [Fig. 1(b)].8 Internalization was blocked in the
presence of excess (100 μM) C-ANF peptide [Fig. 1(c)],
and additionally, LS668 did not internalize into the control
293T-NPR-A cells [Fig. 1(d)], supporting receptor mediated*Address all correspondence to: Monica Shokeen, E-mail: mshokeen@wustl.edu
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endocytosis of LS668. For in vivo imaging, 24-h postinjection of
LS668 was selected as the optimal time point as clearance of
LS668 from blood was achieved at 24 h. Both injured and con-
trol femoral arteries of three animals were imaged at day 3 and
weeks 1, 2, 4, 6, and 8 following the surgery. For each time
point, LS668 (0.1 mg∕kg intravenous) was injected and 24 h
later FMT scans were performed (5 min each) in triplicates
for each artery. FMT reconstruction was performed as reported
earlier to obtain three-dimensional (3-D) data from the tissue
containing the lesion.3 FMT scans of the respective arteries
before surgery were used as blank scans for image
reconstruction. In the reconstructed data, localized fluorescence
signal indicating accumulation of LS668 was observed at a
depth of 4 to 16 mm and over 15 mm of length consistent
with the location of the focal lesion. Coronal section images
of the 3-D volumes are shown at a depth of 7 mm for one rep-
resentative animal [Fig. 2(a)]. The corresponding sagittal and
transverse sections show the spread of the lesion along the
length and breadth [Figs. 2(a) and 2(b)]. Near background signal
from the tissue surrounding the localized fluorescent region
indicated negligible nonspecific uptake by surrounding tissue.
Contralateral noninjured femoral arteries showed minimal signal
indicating negligible background uptake of LS668 in the control
artery. Integrated fluorescence signal (directly related to the
quantity of LS668 in tissue) was calculated from each tissue vol-
ume (thresholded at above 20% of respective maximum signal)
[Fig. 2(c)]. Unpaired t test (two tailed) showed statistically sig-
nificant difference between control and injured arteries at week
Fig. 1 (a) Absorption and fluorescence spectra of LS668 in dimethylsulfoxide. Fluorescence microscopy
images showing cellular internalization of LS668 (b) in NPR-C transfected cells, (c) inhibition of inter-
nalization in presence of excess C-ANF peptide, and (d) absence of internalization in NPR-A transfected
cells. Blue (DAPI, nuclear stain) and red (LS668). Scale: 100 μm.
Fig. 2 (a) Coronal (depth ¼ 7 mm), sagittal and transverse sections of reconstructed fluorescence
molecular tomography (FMT) signal from injured artery and corresponding control artery from a repre-
sentative animal (rabbit 1). White lines indicate the position of the respective sagittal and transverse
sections. (b) Schematic showing the relationship between the FMT images displayed to their orientation
with respect to the tissue volume. (c) Time dependent changes in integrated fluorescence signal
(mean SD, n ¼ 3) for injured and control arteries (*P ¼ 0.0283; **P ¼ 0.0282). (d) Mean (n ¼ 2) fluo-
rescence intensity obtained from the ex vivo injured artery containing the lesion and the control artery.
Adjoining figure (inset) shows the fluorescence images (excitation/emission: 785 nm/ >800 nm) of the
injured artery containing the lesion (top) and the control artery (bottom).
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2 (P ¼ 0.0283) and week 6 (P ¼ 0.0282) [Fig. 2(c)]. The
changes in the signal over time most likely result from a tran-
sient increase in macrophages after injury usually at week 2,
followed by a decrease resulting from the increased amount
of the matrix and decrease in cellularity. Inflammation resumes
in the following days or weeks due to the diet-induced macro-
phage-enriched unstable lesions. The variance within the
cohorts highlights the differences in the pace of lesion formation
in individual animals, probably as a function of their cholesterol
levels. Ex vivo tissue biodistribution even after 24-h postinjec-
tion at week 8 showed ∼3.7-fold (n ¼ 2) higher localization of
LS668 into the injured femoral artery as compared to the control
femoral artery [Fig. 2(d)].
Ex vivo histological validation studies were performed on the
arteries at week 8 following the final imaging session. Prior to
collecting the arterial segments, the vascular system was flushed
with saline and then perfusion fixed with 4% paraformaldehyde
and paraffin embedded. Tissue sections were deparaffinized for
further studies. The bright-field images of the injured artery
showed a thick concentric layer of primary neointima (1°
NEO) within the internal elastic lamina (IEL) [Fig. 3(a)]. The
control artery showed an intact adventitia (A), media (M), and
IEL. Ex vivo staining of the injured artery section with LS668
(10 μM; 30 min; 37°C) followed by fluorescence microscopy
showed an increased signal in the layers between A and the
lumen (L), which is most likely due to the presence of infiltrating
NPR-C expressing macrophages migrating from the adventitia
through the media (smooth muscle cells) to accumulate in the
base of the NEO closest to the media [Fig. 3(b)]. The control sec-
tion had a uniform fluorescence signal akin to nonspecific back-
ground. Histology sections were also stained for macrophages
with mouse monoclonal antibody to rabbit macrophages (clone
RAM11). Positive signal was visualized using alkaline phospha-
tase-conjugated secondary antibody and blue substrate, and
nuclear fast red counterstain. In the injured artery, IHC showed
a thickened adventitial layer and neointima with a dense accumu-
lation of infiltrating macrophages primarily in the adventitial
and medial layers of the injured femoral artery, and also some
in the neointima [Fig. 3(c)]. The control artery showed a negli-
gible staining for macrophages. Serial sections were also stained
for alpha-smooth muscle actin (SMA). The injured artery dem-
onstrated medial hypertrophy and the staining for alpha-SMA
was also markedly higher as compared to the control vessel.
In summary, noninvasive FMT study of atherosclerotic lesions
was conveniently performed weekly/biweekly; a feature that is
not practical for performing similar PET studies. Sequential im-
aging with FMT over several weeks showed quantifiable relative
changes in the fluorescence intensity that provided insights into
receptor concentration as the lesion progressed. This pilot study
demonstrates a unique application of an FMT system for serial
imaging of focal atherosclerotic plaques in the shallow femoral
arteries in a rabbit model of atherosclerosis using a targeted
NIR-fluorescent molecular imaging probe. Future studies will
incorporate additional NIR-fluorescent imaging agents to serially
evaluate the progression of high-risk plaques.
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Fig. 3 Ex vivo studies on the paraffin fixed sections of injured (top row) and control artery (bottom row)
sections obtained at 8 weeks postsurgery. (a) Bright field images showing IEL, internal elastic lamina; A,
adventitia; M, media; 1° NEO, primary neointima. Scale: 500 μm. (b) Corresponding fluorescence images
(excitation/emission: 710 75nm∕810 90 nm) after ex vivo staining with LS668. Scale: 500 μm.
(c) Immunohistochemistry on tissue sections with clone RAM11 antibody (1: 100 dilution; blue) for macro-
phages and counterstained with nuclear fast red. Scale: 250 μm.
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